Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent

Bhadriraju Satish; Kellogg Tressa; Chandra R. Harish

doi:10.1097/01.hpc.0000255061.30935.f4

Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent

Bhadriraju Satish, Kellogg Tressa, Chandra R. Harish

General Internal Medicine

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Antiplatelet agents are indicated after coronary stenting to prevent stent thrombosis and these should not be inadvertently discontinued after stenting. Adverse effects from the use of these drugs may require use of alternative agents.

Original language	English (US)
Pages (from-to)	24-25
Number of pages	2
Journal	Critical Pathways in Cardiology
Volume	6
Issue number	1
DOIs	https://doi.org/10.1097/01.hpc.0000255061.30935.f4
State	Published - Mar 2007

Keywords

Coronary stenting
Rash
Thienopyridines

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1097/01.hpc.0000255061.30935.f4

Cite this

@article{b850e0632a2f4d0aa5ddb2065610e77d,

title = "Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent",

abstract = "Antiplatelet agents are indicated after coronary stenting to prevent stent thrombosis and these should not be inadvertently discontinued after stenting. Adverse effects from the use of these drugs may require use of alternative agents.",

keywords = "Coronary stenting, Rash, Thienopyridines",

author = "Bhadriraju Satish and Kellogg Tressa and Harish, {Chandra R.}",

year = "2007",

month = mar,

doi = "10.1097/01.hpc.0000255061.30935.f4",

language = "English (US)",

volume = "6",

pages = "24--25",

journal = "Critical Pathways in Cardiology",

issn = "1535-282X",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent

AU - Satish, Bhadriraju

AU - Tressa, Kellogg

AU - Harish, Chandra R.

PY - 2007/3

Y1 - 2007/3

N2 - Antiplatelet agents are indicated after coronary stenting to prevent stent thrombosis and these should not be inadvertently discontinued after stenting. Adverse effects from the use of these drugs may require use of alternative agents.

AB - Antiplatelet agents are indicated after coronary stenting to prevent stent thrombosis and these should not be inadvertently discontinued after stenting. Adverse effects from the use of these drugs may require use of alternative agents.

KW - Coronary stenting

KW - Rash

KW - Thienopyridines

UR - http://www.scopus.com/inward/record.url?scp=33947119552&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947119552&partnerID=8YFLogxK

U2 - 10.1097/01.hpc.0000255061.30935.f4

DO - 10.1097/01.hpc.0000255061.30935.f4

M3 - Article

C2 - 17667883

AN - SCOPUS:33947119552

SN - 1535-282X

VL - 6

SP - 24

EP - 25

JO - Critical Pathways in Cardiology

JF - Critical Pathways in Cardiology

IS - 1

ER -

Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this